PT Metro Healthcare Indonesia Tbk (IDX: CARE)
Health Care · Health Care Providers & Services · ID
Rp378.00
+1.61% today · +26.0% 1Y
PT Metro Healthcare Indonesia Tbk (IDX: CARE) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $702.39M and employs 866 people.
Over the last twelve months the share price has gained 26.0%, trading between 290.00 and 965.00.
Tweenvest scores PT Metro Healthcare Indonesia Tbk across four factors: quality 52/100, value 41/100. Its strongest factor is quality.
CARE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $702.39M
- Revenue (TTM)
- $27.57M
- P/E
- —
- EPS
- 0.18
- Dividend yield
- —
- Beta (5Y)
- -0.43
- 52-week high
- Rp965.00
- 52-week low
- Rp290.00
- Avg volume (3M)
- —
- Shares outstanding
- 33.25B
- Employees
- 866
- Next earnings
- —
About PT Metro Healthcare Indonesia Tbk
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; health support facilities and support services; and real estate and retail trading services. It also offers management consulting services; and operates private polyclinics. The company was founded in 2015 and is based in Tangerang, Indonesia.
- ISIN
- ID1000154909
- Founded
- 2015
- Listed since
- Mar 13, 2020
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| WELL Health Technologies Corp.TSX: WELL | $742.64M | CA$4.14 | -3.94% |
| Realcan Pharmaceutical Group Co., Ltd.SZSE: 002589 | $735.24M | CN¥3.35 | +2.45% |
| Gushengtang Holdings LimitedSEHK: 2273 | $721.81M | HK$26.74 | +0.83% |
| Amal Holdings A.D. Ltd.TASE: AMAL | $714.78M | ₪15.64 | -1.64% |
| Shanghai Labway Clinical Laboratory Co., LtdSZSE: 301060 | $700.88M | CN¥11.78 | -2.00% |
| Bright Eye Hospital Group Co., Ltd.SZSE: 301239 | $696.30M | CN¥31.33 | -2.03% |
| Middle East Healthcare CompanySASE: 4009 | $678.06M | SR27.66 | -1.98% |
| Starling Oncology, Inc.NasdaqCM: STLN | $675.70M | $6.81 | +2.71% |
Figures last refreshed Oct 11, 2026.